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Abstract The casein kinase from the Golgi apparatus of 
lactating mammary gland (GEF-CK) is distinct from ubiquitous 
'casein kinases' termed protein kinases CKI and CK2 and 
appears to define a family of secretory pathways protein kinases 
that phosphorylate seryl residues followed by an acidic residue at 
position +2. In this report we show that a new synthetic peptide 
subetrate derived from [i-casein ([1128--40D issuitable for the fast, 
efficient and selective monitoring of GEF-CK, being unaffected 
by CKI and CK2, and we define the consensus sequence of this 
protein kinase a~ being Ser.Xaa-Giu/SerP, distinct from that of 
CK2 (Ser/Thr.X-X.GlulAsp/SerPrryrP). In particular, the fail- 
ure to recognize Asp as crucial specificity determinant prevents 
the phosphorylation of the specific CK2 peptide substrate 
RRRADDSDDDDD by GEF-CK. Thus, peptide substrates are 
now available for the fast and specific monitoring of all the three 
classes of 'casein kinases', CKI, CK2 and GEF-CK. 
Key words: Casein kinase; Protein kinase CKI; Protein 
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CK2, including multiple acidic residues downstream from ser- 
ine are also readily phosphorylated by GEF-CK [9]. In con- 
trast, it has been observed that several phosphorylated sites 
present in naturally occurring phosphoproteins, e.g. pepsin, 
ovoalbumin, ACTH, fibrinogen, exhibit the minimal S-X- 
acidic-X sequence which is not suitable for CK2 while it could 
be phosphorylated by a protein kinase having the same site 
specificity as GEF-CK [2]. Indeed, the phosphorylation f pre- 
viously dephosphorylated pepsin by a crude preparation of 
bovine mammary gland casein kinase has been reported [4]. 
These observations prompted us to start a thorough char- 
acterization of GEF-CK, having the ultimate goal of tmravel- 
ing its primary structure and assessing the presence of related 
enzymes in tissues other than the mammary gland. 
Here we report he design of a peptide substrate suitable for 
the selective detection and monitoring of GEF-CK and pro- 
tein kinase(s) sharing tile same consensus equence and we 
disclose additional features that differentiate the specificity 
of GEF-CK from those of CK2 and CK1. 
1. Introduction 2. Materials and methods 
Most Serfrhr protein kinases recognize consensus sequences 
specified by basic residues situated in the proximity of the 
target amino acid. A minority of Ser/Thr protein kinases how- 
ever use acidic residues as specificity determinants [1]. Sympto- 
matic of such an acidophilic nature often is the attitude to 
phosphorylate casein in vitro, whence the operational term 
'casein kinase' commonly applied to three different kinds of 
acidophilic SerlThr protein kinases [2]. Two of these, however, 
formerly termed casein kinasos 1 and 2, are ubiquitous and 
pleiotropic protein kinases, functionally unrelated with casein 
and thereafter recently re-termed protein kinases CKI and 
CK2 (reviewed in [3]). A third class of casein kinases includes 
the enzyme(s) committed with the biosynthetic phosphoryla- 
tion of casein and mainly localized in the Golgi apparatus of 
the mammary gland [4,5]. In contrast to CK2 and CKI, these 
genuine casein kinase(s) have been only poorly characterized, 
mostly using crude extracts of mammary gland particulate 
fractions. A genuine casein kinase termed 'Golgi.enriched frac- 
tion casein kinase' (GEF-CK) has been isolated from guinea- 
pig mammary gland and partially purified as an about 70 kDa 
enzyme [6,7]. As expected GEF-CK was able to phosphorylate 
dephosphorylated casein at the same sites which are phos- 
phorylated in native casein. From both the inspection of these 
sites [8] and studies with synthetic peptide substrates [9,10] it 
was concluded that the consensus equence of GEF-CK is S- 
X-acidic, which is distinct from but similar to that of CK2 (S/ 
T-X-X-acidic). Consequently the best peptide substrates for 
*Corresponding author. Fax: (39) (49) 8073310. 
2.1. 'Casein kinases' 
Isolation and partial purification of a membrane-bound casein ki- 
nase from the Golgi-enriched fraction of rat lactating mammary gland 
was performed as in [7] using ATP-agarose column chromatography. 
Rat liver protein kinases CKI and CK2 were purified as previously 
described [1!]. 
2.2. Synthetic peptides 
The peptides KKIEKFQSEEQQQ, KKIEKFQSAEAAA, 
RRRAEESEEEEE, RRRAEESEAEEE, RRRADDSDEDDD were 
prepared in solid phase peptide synthesis by Fmoc (9.fluorenyl- 
methoxycarbonyl) chemistry, using an automatic synthesizer (model 
431 A, Applied Biosystems) at 0.05 mmol scale as previously de- 
scribed [12]. The peptides RRRAEESEDEEE and SSSDD were 
synthesized by a manual procedure as described in [i ~! ,'o:~'g Fmoc 
solid-phase chemistry on a polystyrene support (Wang resin) pre- 
loaded with the first amino acid (0.9 mmol/g). After the purification 
of the peptides, the purity, checked by amino acid analysis and ana- 
lytical HPLC, was ~95%. The synthesis of the peptide SSSEE, 
SSSSpSp, SSSTpTp and SSSYpYp is described elsewhere [14]. The 
peptides RRREEESDDD and RRRDDDSEEE were kindly provided 
by Dr. e.G. lssinger (Homburg). 
2.3. Phosphorylation assays 
GEF-CK (0.8-1.2 I~g) was incubated for 20 min at 30°C in a med- 
ium containing 80 mM MOPS pH 6.3, 15 mM MgCI2, 15 mM MnCI2, 
100 ~tM [¥-a2p]ATP (spec. act. 500 cpm/pmol) inthe presence ofeither 
casein or peptide substrates. The concentration f casein was I mg/ml 
and that of peptide substrates was 1 mM0 unless differently indicated. 
Incorporation of :~2p was evaluated by either the phosphocellulose 
paper procedure [15] or following partial acid hydrolysis ofthe phos- 
phorylated peptide and isolation of radioactive phosphoamino acids 
as described in [16]. CKi and CK2 were assayed as previously de- 
scribed [12]. Kinetic constants ofpeptide substrates were determined 
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Table I 
Selective phoslxhorylation of peptide substrates bythree distinct 'casein kinases' 
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Phosphorylation rate (pmol'min -~) by 
GEF-CK CIC2 CK! 
! KKIEKFQSEEQQQ 3.81 0.01 0.02 
!I KK[EKFQSAEAAA 1.85 <0.01 <0.01 
!11 RRRADDSDDDDD 0.32 2.03 0 04 
IV RRK DLHDDEEDEAMSITA 0.43 0. ! 3 4.52 
Casci~ 1.00 1.00 1.00 
All peptide substrates were 1 raM. The amounts of GEF-CK, CK2 and CKI were equivalent toone unit of casein kinase activity, correspond- 
ing to 1 pmol P transferred from ATP to casein per rain. Experimental conditions are either detailed or referenced m section 2, except for 
ATP concentration that was 160 ~¢M also with CK2 and CKI. Peptide 1 corresponds to the 28-40 sequence of [~-caa~in [17]. Peptide II is a 
variant of peptide I in which the a~,~fications are underlined. Peptides III and IV are optimal model substrates for CK2 and CKI, respectively 
[12]. 
by regre~on analysis of doubleo~i~oca'~ i~lot~ o.~:~sructed front 
initial rate ~rements .  
3. Results 
Searching for a synthetic ~p¢ide sut~strate specific for 
GEF-CK, the s~.quence around Ser-35 of I~-casein was chosen 
because this residue is fully ph~sphorylated in native [}.casein 
[17] and, unlike otl~er phosphQtviated sites of casein, it dis- 
plays the canonical consensus for GEF-CK (S-X-E) but not 
that for CK2 (S.X.X-FJDL This peptide would be expected 
therefore to be phosphoryiated by GEF-CK alone, by con- 
trast to the other phosphoseryi s te of 13-casein (Ser 17-19) 
which is an excellent phesphoacceptor substrata for CK2 as 
well [10]. The natucai sequence of the [3128--40] peptide more- 
over includes 3 iysyl residues uitable for the fast and simple 
phosphoceUulose assay [15]. A derivative of the ~[28-40] pep- 
tide was also prepared in which glutamic acid at position + i, 
a positive, albeit not sufficient determinant for phosphoryla- 
tion by CK2 [18], was replaced by alanine, with the aim to 
reduce further the probability of phosphorylation by CK2, 
The phosphorylation of these peptides by equivalent 
amounts (in terms of casein kinase units) of GEF-CK, CK2 
and CKI are reported in Table I, where they are compared 
with the specific peptide substrates for CK2 and CKI. It can 
be seen that the 13128-40] peptide is readily phosphorylated by
GEF-CK alone, both CK2 and CKI being practically ineffec- 
tive on it, Such an outcome makes the replacement of gluta- 
mi¢ acid at position +1 unnecessary for improving specificity 
(compare peptides I and !! in Table I). 
Table I also shows that GEF-CK is nearly inactive on 
either the CK2 or the CKI peptide substrates. While its in- 
capability to phosphorylate he CK! peptide was expectable, 
its failure to phosphorylate he CK2 peptide came as a sur- 
prise considering that this peptide includes an aspartic acid at 
position +2 and that other peptides with similar acidic clusters 
downstream from serine, like SEEEEE, are exct;llent sub- 
strates for both CK2 and GEF-CK [9]. 
A possible xplanation for the failure of GEF-CK to phos- 
phorylate the RRRADDSDDDDD peptide substrata of CK2 
could be that aspartic acid cannot replace glutamic acid in the 
consensus equence recognized by GEF-CK. To check this 
hypothesis a series of derivatives of the RRRADDSDDDDD 
peptide in which aspartyl residues were variably replaced by 
81utamyl ones were assayed as substrates for GEF-CK (Table 
2). It can be seen that indeed the replacement of the individual 
aspartic acid at position +2 with glutamic acid in the peptide 
RRRADDSDDDDD (to give RRRADSDEDDD) is suffi- 
cient to convert a nearly inert substrate into the best substrate 
among those of Table 2. In a specular way the phosphoryla- 
tion of the excellent peptide substrata RRRAEESEEEEE is 
compromised by the individual replacement of Glu by Asp at 
position +2, almost as severely as by substituting Glu by Ala. 
Additional evidence that glutamic acid but not aspartic acid 
can act as crucial specificity determinant with GEF-CK i~ 
provided by comparing the peptides RRRDDDSEEE and 
SSSEE (both good substrates) with RRRDDDSDDD and 
SSSDD, respectively, both of which are almost unaffected. 
The failure of aspartic acid to surrogate glutamic acid in the 
consensus equence for GEF-CK prompted us to assess the 
efficacy of phosphorylated residues as well, two of which, 
namely TyrP and SerP are known to act as powerful specifi- 
city determinants with CK2 [14]. The data of Table 2 clearly 
show that neither phosphotyrosine or phosphothreonine can 
surrogate glutamic acid in peptides exhibiting the consensus 
sequence for GEF-CK (compare peptide 11 with peptides 14 
and 15), while phosphoserine does act as specificity detern:i- 
nant, less effectively however than glutamic acid (compare 
peptide !1 with peptide 13). 
The kinetic constants of GEF-CK for its peptide substrates 
Table 2 
Specificity determinants of GEF-CK: effect of substituting glutamic 
acid by other esidues 
Phosphorylation rate 
(pmol. min -! .mg -I) 
I KK IEKFQSEEQQQ 1433 
2 KK IEKFQSAEAAA 885 
3 RRRAEESEEEEE 1632 
4 RRRAEESED_EEE 418 
5 RRRAEESEAEEE 169 
6 RRRADDSDDDDD 193 
7 RRRADDSDEDDD 2346 
8 RRRDDDSDDD 103 
9 RRREEESDDD 99 
I0 RRRDDDSEEE 1722 
I I SSSEE 1303 
12 SSSDD 207 
13 SSSSpSp 436 
14 SSSTpTp n.d.a 
15 SSSYpYp n.d." 
The concentration f all peptides was I mM. Experimental condi- 
tions are detailed in section 2. Peptide I is the 13128-40] peptide cor- 
responding to the 28-40 sequence of 13-casein. Peptides 3-7 are var- 
iants of the peptide RRRAEESEEEEE, changes from which are 
underlined. 
aNot detectable. 
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Table 3 
Kinetic constants of peptide substrates for GEF-CK (A) and CK2 (B) 
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Ks ($tM) F~m~ Vm~/Km 
(A) GEF-CK 
1 KKIEKFQSEEQQQ 663 2747 4.14 
2 KKIEKFQSAEAAA 785 1743 2.22 
3 RRRAEESEEEEE 15 2350 156.66 
4 RRRAEESEDEEE 1720 1198 0.69 
5 RRRAEESE_AEEE 2805 654 0.23 
6 RRRADDSDDDDD 3062 454 0.14 
7 RRRADDSDEDDD 65 2571 39.55 
8 RRRDDDSDDD 2218 224 0.10 
9 RRREEESDDD 1438 112 0.07 
10 RRRDDDSEEE 43 1783 41.46 
11 SSSEE 285 2164 7.59 
12 SSSDD n.m. b n.m.b n'm'b 
i 3 SSSSpSp 657 1114 1.69 
(n) oK2 
3 RRRAEESEEEEE 23 74 3.21 
4 RRRAEESEDEEE 13 149 11.46 
5 RRRAEESEAEEE 19 86 4.52 
6 R RRAD.~SD.]3D_D_D_D_D_D_D~ ! 3 I ! 6 8.92 
7 RRAD.O~S_DEI~D_~ 19 137 7.21 
Kinetic experiments were performed as described in section 2. Peptides 3--7 are variants of the peptide RRRAEESEEEEE, changes from which 
are underlined. Values are means of at least hree determinations with a standard error less than 15%. 
"V,,,,,~ values are expressed either in pmol mia "l mg -i (A) or nmol raiu -I mg -I (B). 
~'Not measurable due to too low a phosphorylation rate. 
are reported in Table 3A. They show that the beneficial effect 
of glutamic acid at position +2 as compared to aspartic acid is 
largely accounted for by differences in Km values, increasing, 
e.g. from 15 to 1720 ~tM by just replacing Asp for Glu at 
position +2 in the peptide RRRAEESEEEEE (to give 
RRRAEESED_EEE), and conversely dropping from 3,062 to 
65 I.tM if Asp is replaced by Glu at position +2 in the peptide 
RRRADDSDDDDD (to give RRRADDSDEDDD). In this 
latter case also the Vm~ is greatly altered, increasing fron~ 454 
to 2,571 pmol min -1 mg -l.  A similar change of both Km and 
Vm~ is found between the related peptides RRRDDDSEEE 
and RRRDDDSDDD, the overall phosphorylation efficiency 
of the latter resulting 500-fold lower than that of the former 
peptide. 
Interestingly the behaviour of CK2 is opposite under this 
respect since it displays a preference for an aspartic over a 
glutamic acid at position +2 (see Table 3B). The kinetic con- 
stants of Table 3B also corroborate the concept hat position 
+2 is relatively unimportant for substrate recognition by CK2 
since even a neutral residue in that position is not harmful, 
giving rise to a derivative (RRRAEESE_AEEE) which is phos- 
phorylated slightly better than the parent peptide with a glu- 
tamic acid there, though somewhat less efficiently than the 
derivative with Asp instead of Ala. This further differentiates 
CK2 from GEF-CK, whose requirement for a glutamic acid 
(or phosphoserine) at position +2 is absolute [9]. 
The kinetic constants of Table 3A also show that the spe- 
cific peptide substrate [3128-40] exhibits the highest Vm~ value 
but a relatively high Km value (663 gM) as compared to more 
acidic peptides, corroborating the concept [9] that muRiple N 
terminal acidic residues in addition to that at position +2, 
though not required for optimal phosphorylation rate, in- 
crease the affinity for the enzyme. In this respect the low 
Km value of the peptide RRRADDSD_EDDD is noteworthy 
since in it the acidic residues at positions other than +2 are 
those of aspartic acid, i.e. an amino acid which at position +2 
fails to act as specificity determinant (see above). It should be 
concluded therefore that while the consensus equence for 
GEF-CK is S-X-E/Sp, excluding aspartic acid as specificity 
determinant a position +2, aspartyl residues may nevertheless 
play a favourable role on Km if present at different positions. 
4. Discussion 
Despite the fact that casein was the first phosphorylated 
protein to be detected, over one century ago [22] and therefore 
casein kinase(s) were the first protein kinases whose existence 
was implicitly recognized, very little is known about these 
enzymes. Their primary structure is still obscure in sharp con- 
trast with the detailed knowledge we already have of the 
structure of more than 300 younger members of the protein 
kinase superfamily [23] and their catalytic and regulatory 
properties are very poorly understood. This lack of informa- 
tion is especially regrettable considering that it is expectable 
Table 4 
Specificity determinants for GEF-CK, CK2 and CKP 
Residue specificity Crucial position h Specificity determinants atcrucial position Specific peptide substrates 
GEF-CK Ser n + 2 Giu > Ser-P 
KKIEKFQSEEQQ~ 
CK2 Ser > Thr n + 3 
CKI Ser > Thr:~Tyr n - 3 
Tyr-P > Glu ---- Asp -- Ser-P > Thr-P ~ Tyr 
Ser-P > Thr-P ~ Asp > Glu 
abased on data drawn from this paper as well as from [12,14,19-21]. 
bRelative to that of the phosphorylatable residue (n +- 0). 
RRRADDSDDDDD 
RRKDLHDDEEDEAMSITA 
152 
that casein kinase(s) or related enzymes .'~th the same speci- 
ficity are also expressed in tissues other than lactating mam- 
mary gland, possibly representing a class of Ser-X-Glu/SerP 
specific secretory pathway protein kinases. This postulate is 
grounded on the observation that in several secreted phospho- 
proteins the phosphorylated sites strictly conform to the mini- 
mum S-X-E/Sp consensus equence [2,24,25] which is recog- 
nized by GEF-CK but neither by CK2 nor by CKI; it has 
been also recently corroborated by the detection in rat liver of 
a CKI/CK2 unrelated protein kinase displaying a specificity 
similar to that of genuine casein kinase [26]. 
The main outcomes of the present study, aimed at a better 
understanding of the casein kinase extracted from the Golgi 
apparatus of rat lactating mammary gland (GEF-CK), are the 
following. 
I, A specific substrate reproducing the 28--40 sequence of ~- 
casein has been developed for monitoring the activity of case- 
in kinase. This peptide, unlike casein, is not phosphorylated 
by the other members of the 'casein kinase' family, namely 
ubiquitous protein kinases CKI and CK2, while it is phos- 
phorylated more readily than casein itself by GEF-CK (see 
Table !). The [5128-40] peptide will prove also useful for the 
detection and monitoring of 'casein kinases' different from 
CKI and CK2 in tissues other than mammary gland [26]. 
2, The structural requirements of GEF-CK have been 
further defined by showing that neither aspartic acid nor the 
phosphoamino acids TyrP and ThrP can substitute for gluta- 
mic acid in the consensus equence S-X-E-X. Only phospho- 
serine can replace glutamic acid, albeit less efficiently. The 
failure of aspartic acid to replace glutamic acid as specificity 
determinant is in agreement with the analysis of the potential 
sites that are actually phosphorylated in casein fractio~ls [8] 
and it may account for the observation tttat potential phos- 
phoacceptor sites in iysozyme, having the S-X-D sequence, 
could not be phosphorylated by a casein kinase preparation 
from bovine mammary gland, despite their similarity to se- 
quences readily phosphorylated in wlactalbumin, displaying 
however aS-X-E motif [27], GEF-CK is therefore the member 
of the 'casein kinase' family endowed with the most stringent 
specificity, as summarized in Table 4, where the elements con- 
tributing to the consensus equences of CKI, CK2 and GEF- 
CK are compared, Unlike CKI, which is capable to phos- 
phorylate also tyrosine, under certain circumstances [28], 
and CK2, which tolerates a variety of acidic and phosphory- 
lated residues as specificity determinants [18], GEF-CK dis- 
plays the highest selectivity toward serine as opposed to threo- 
nine [9] and tolerates only glutamic acid and, to a lesser extent 
phosphoserine, as specificity determinants. 
3, The very low activity of GEF-CK toward the optimal 
CK2 substrate RRRADDSDDDDD corroborates the con- 
cept that this peptide is highly selective for CK2 alone [12]. 
Consequently three peptide substrates (listed in Table 4) are 
now available for the specific monitoring of each of the three 
known members of the 'casein kinases' family, namely GEF- 
CK, CK! and CK2. 
The new information provided by this study will prove 
helpful both for the further characterization of OEF-CK 
and for the detection of'casein kinases' with similar specificity 
in organisms and tissues other than the lactating mammary 
gland. 
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